null

SMILES: Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCS(=O)(=O)CC2)CC1

InChI Key: InChIKey=SQXPURWSUNRRIZ-PGWJBFNOSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 180711   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
5-hydroxytryptamine receptor 2A (Homo sapiens (Human))	BDBM180711 (US8829029, 11) Show SMILES Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCS(=O)(=O)CC2)CC1 |r,wU:19.24,wD:16.17,(-4.9,-7.48,;-5.3,-5.99,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.41,-.44,;-3.92,-.84,;-2.83,.25,;-3.23,1.74,;-2.14,2.83,;-.65,2.43,;.44,3.52,;1.93,3.12,;3.01,4.21,;2.62,5.7,;1.13,6.1,;.04,5.01,;3.7,6.79,;5.19,6.39,;6.28,7.48,;5.59,4.9,;4.5,3.81,;4.9,2.32,;6.39,1.93,;7.48,3.01,;7.08,4.5,;6.79,.44,;5.7,-.65,;6.1,-2.14,;7.58,-2.54,;7.18,-4.02,;8.67,-3.63,;8.67,-1.45,;8.27,.04,;-4.72,2.14,;-5.8,1.05,)| Show InChI InChI=1S/C31H39FN4O4S/c32-25-5-10-28-29(21-25)40-34-30(28)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-41(38,39)20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37)/t22-,26-	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	2.48	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Hoffmann-La Roche Inc. US Patent					Assay Description Aliquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC...				US Patent US8829029 (2014) BindingDB Entry DOI: 10.7270/Q22B8WSS
					More data for this Ligand-Target Pair
D(3) dopamine receptor (Homo sapiens (Human))	BDBM180711 (US8829029, 11) Show SMILES Fc1ccc2c(noc2c1)C1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccc(cc2)N2CCS(=O)(=O)CC2)CC1 |r,wU:19.24,wD:16.17,(-4.9,-7.48,;-5.3,-5.99,;-4.21,-4.9,;-4.61,-3.41,;-6.1,-3.01,;-6.49,-1.53,;-7.98,-1.13,;-8.67,-3.7,;-7.18,-4.1,;-6.79,-5.59,;-5.41,-.44,;-3.92,-.84,;-2.83,.25,;-3.23,1.74,;-2.14,2.83,;-.65,2.43,;.44,3.52,;1.93,3.12,;3.01,4.21,;2.62,5.7,;1.13,6.1,;.04,5.01,;3.7,6.79,;5.19,6.39,;6.28,7.48,;5.59,4.9,;4.5,3.81,;4.9,2.32,;6.39,1.93,;7.48,3.01,;7.08,4.5,;6.79,.44,;5.7,-.65,;6.1,-2.14,;7.58,-2.54,;7.18,-4.02,;8.67,-3.63,;8.67,-1.45,;8.27,.04,;-4.72,2.14,;-5.8,1.05,)| Show InChI InChI=1S/C31H39FN4O4S/c32-25-5-10-28-29(21-25)40-34-30(28)23-12-15-35(16-13-23)14-11-22-1-6-26(7-2-22)33-31(37)24-3-8-27(9-4-24)36-17-19-41(38,39)20-18-36/h3-5,8-10,21-23,26H,1-2,6-7,11-20H2,(H,33,37)/t22-,26-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	4.67	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Hoffmann-La Roche Inc. US Patent					Assay Description Aliquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC...				US Patent US8829029 (2014) BindingDB Entry DOI: 10.7270/Q22B8WSS
					More data for this Ligand-Target Pair